Airdate: Friday, December 2, 2022 Season: 9 Episode: 46
Guests: Gera Goverse, Rajendra Kumari
In this episode of #ExpertAnswers, Dr. Rajendra Kumari and Dr. Gera Goverse from Crown Bioscience answer questions from a recent webinar where they provide an overview of the cancer immunity cycle and present several methods, techniques, and model systems for immuno-oncology research.
To watch the webinar, click here.
Associated Webinar: Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
Similar Podcasts
#ExpertAnswers: Steven Loo-Yong-Kee on CRISPR-Edited T Cells
Steven Loo-Yong-Kee highlights Artisan Bio’s STAR-CRISPR system for optimized gene editing in cell therapy, with a focus on the genetic modification of T cells for cancer immunotherapy.
Talking Real Science with Ellie Siebeneck
Ellie Siebeneck is one of 10 winners of the inaugural Scientist.com STEM Research NIL Award. In this episode, she discusses her passion for learning, mentorship and where the road lies ahead for her academic journey.
Industry Insights with Crown Bioscience: Analyzing the Suppressive TME in In Vitro Based Assays
Nataliia Beztsinna and Marten Hornsveld from Crown Bioscience talk about native and reconstituted TME assays, how they can help in the preparation for clinical trials, and what kinds of therapies in development would benefit the most from this kind of testing.
Related Content
Revolutionizing Immunotherapy Research with 3D, Multiplexed Cryo-fluorescence Tomography
Dr. Matt Silva showcases the power of cryo-fluorescence tomography (CFT) in advancing immunotherapy research.
Unlocking Spatial Insights: Accelerate Discoveries 70% Faster with SignalStar™ Multiplex IHC
Join us to learn how to accelerate spatial biology discoveries by 70% with optimized, ready-to-go panels using SignalStar™ Multiplex IHC.
Overcome the Multiple Challenges of Neutralizing Antibodies in Cancer Therapy Using Innovative Phage Display Technologies
In this webinar, Dr. Conor McCartin discusses how phage display can be used for human antibody development.